
Science Resources RSS Feeds
|
 |
 |
 |
Commonly used medications associated with impaired physical function in older adults
May 05, 2008
WINSTON-SALEM, N.C. - Older adults who take drugs designed to block the neurotransmitter acetylcholine - including common medications for incontinence, high blood pressure and allergies - are more likely to be dependent in one or more activities of daily living and to walk slower, according to new findings from researchers at Wake Forest University School of Medicine and colleagues. The findings, which involve a class of drugs known as anticholinergic medications, are from the Ginkgo Evaluation of Memory Study (GEMS) and will be presented at the American Geriatrics Society Meeting in Washington, D.C., on May 3.
"These results were true even in older adults who have normal memory and thinking abilities," said Kaycee M. Sink, M.D., M.A.S., lead author. "For older adults taking a moderately anticholinergic medication, or two or more mildly anticholinergic medications, their function was similar to that of someone three to four years older."
In a separate study reported this month in the Journal of the American Geriatrics Society, Sink found that older nursing home residents who took medications for dementia and anticholingeric medications for incontinence at the same time had a 50 percent faster decline in function than those who were being treated only for dementia.
Over a year's time, the decline would represent a resident going from requiring only limited assistance in an activity to being completely dependent, or from requiring only supervision to requiring extensive assistance in an activity.
Sink said that the two studies together suggest that physicians should carefully consider the implications when prescribing anticholingeric medications to older adults.
"Because these medications are so commonly prescribed, older adults who take multiple medications are at increased risk of taking one or more anticholinergic-containing medications," said Sink. "The potential effects on physical function represent a significant public health problem."
Many medications have anticholinergic properties including some for high blood pressure, some antidepressants, most allergy medicines and incontinence medicines. Some of the most common anticholinergics in the GEMS participants include the blood pressure medication nifedipine (Adalat® or Procardia®), which has mild anticholinergic properties, the stomach antacid ranitidine (Zantac®), which has moderate anticholinergic properties, and the incontinence medication tolterodine (Detrol®), which is highly anticholinergic.
In the GEMS study, the researchers sought to determine the effects of taking multiple anticholinergic drugs on walking speed and the ability to independently perform activities of daily living such as dressing, personal hygiene, toileting, transferring, bed mobility and eating as well as higher order activities including shopping, cooking, managing money, doing light housework and using a telephone.
The findings are from more than 3,000 people with an average age of 78 years. Almost half (40 percent) of participants were taking more than one anticholinergic drug. The researchers found that higher anticholinergic burden is associated with worse physical function, both self-reported and performance-based.
Wake Forest University Baptist Medical Center
|
 |
Related Anticholinergic Current Events and Anticholinergic News Articles Commonly used medications may produce cognitive impairment in older adults Many drugs commonly prescribed to older adults for a variety of common medical conditions including allergies, hypertension, asthma, and cardiovascular disease appear to negatively affect the aging brain causing immediate but possibly reversible cognitive impairment, including delirium, in older adults.
Dual treatment of incontinence and dementia associated with functional decline Older nursing home residents who took medications for dementia and incontinence at the same time had a 50 percent faster decline in function than those who were being treated only for dementia, according to a study from researchers at Wake Forest University School of Medicine and colleagues.
Journal Studies Find Relationship Between Delirium, Dementia Dementia, including Alzheimer's disease, is one of the most devastating conditions of older age. Currently affecting nearly 7 million individuals in the U.S. and 24 million worldwide, dementia leads to total loss of memory and the ability to function independently-making it one of people's greatest fears of aging.
Relationship between delirium and dementia Dementia, including Alzheimer's disease, is one of the most devastating conditions of older age. Currently affecting nearly 7 million individuals in the U.S. and 24 million worldwide, dementia leads to total loss of memory and the ability to function independently - making it one of people's greatest fears of aging.
Anticholinergic drugs linked to mental impairment in elderly people Anticholinergic drugs may lead to mild cognitive (mental) impairment in elderly people, finds a study published online by the BMJ today. More Anticholinergic Current Events and Anticholinergic News Articles
|
 |
|
|
Avoid the side effects of anticholinergic medications: this broad class of drugs may affect cognitive and physical function, so talk to your doctor about ... An article from: Men's Health Advisor
by Unavailable (Author)
This digital document is an article from Men's Health Advisor, published by Belvoir Media Group, LLC on October 1, 2008. The length of the article is 663 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Avoid the side effects of anticholinergic medications: this broad class of drugs may affect cognitive and physical function, so talk to your doctor about the medicines you take.(Medicine chest) Author: Unavailable Publication: Men's Health Advisor (Magazine/Journal) Date: October 1, 2008 Publisher: Belvoir Media Group, LLC Volume: 10 Issue: 10 Page: 6(1)
Distributed by Gale, a part of...
|

|
Anticholinergic Agents Labels - Atropine Sulfate___mg/ml - Anticholinergic Agents Labels
by Lab Products
Anticholinergic Agents Labels - ATROPINE SULFATE___mg/mL - Anticholinergic Agents Labels : Color-coded by drug category. No minimum order required. Designed to include expiration date, expiration time, and initials of healthcare provider. Packaged on rol
|

|
The 2007-2012 World Outlook for Antispasmodic and Anticholinergic H2 Blocking Agents
by Philip M. Parker (Author)
This study covers the world outlook for antispasmodic and anticholinergic H2 blocking agents across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might...
|
|
|
Safety data mixed on anticholinergics for COPD.(Pulmonary Medicine)(chronic obstructive pulmonary disease): An article from: Internal Medicine News
by Mitchel L. Zoler (Author)
This digital document is an article from Internal Medicine News, published by International Medical News Group on December 15, 2008. The length of the article is 1119 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Safety data mixed on anticholinergics for COPD.(Pulmonary Medicine)(chronic obstructive pulmonary disease) Author: Mitchel L. Zoler Publication: Internal Medicine News (Magazine/Journal) Date: December 15, 2008 Publisher: International Medical News Group Volume: 41 Issue: 24 Page: 22(2)
Distributed by Gale, a part of Cengage...
|

|
The 2007-2012 Outlook for Synthetic Antispasmodics and Anticholinergics Pharmaceutical Preparations in the United States
by Philip M. Parker (Author)
This study covers the latent demand outlook for synthetic antispasmodics and anticholinergics pharmaceutical preparations across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 5,100 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for synthetic antispasmodics and...
|

|
The 2007-2012 Outlook for Antispasmodic and Anticholinergic Pharmaceutical Preparations Excluding Synthetic and H2 Blocking Agents in India
by Philip M. Parker (Author)
This study covers the latent demand outlook for antispasmodic and anticholinergic pharmaceutical preparations excluding synthetic and H2 blocking agents across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 2,600 cities in India. For each city in question, the percent share the city is of it’s state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state or union territory and city, latent demand...
|

|
The 2006-2011 World Outlook for Synthetic Antispasmodics and Anticholinergics Pharmaceutical Preparations
b
WHAT IS LATENT DEMAND AND THE P.I.E.?
The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized. Demand is the notion of an economic quantity that a target population or market requires under different assumptions of price, quality, and distribution, among other factors. Latent demand, therefore, is commonly defined by economists as the industry earnings of a market when that market becomes accessible and attractive to serve by competing firms. It is a measure, therefore, of potential industry earnings (P.I.E.) or total revenues (not profit) if a market is served in an efficient manner. It is typically expressed as the total revenues potentially extracted by firms. The “market” is defined at...
|

|
The 2007-2012 Outlook for Antispasmodic and Anticholinergic H2 Blocking Agents in Greater China
by Philip M. Parker (Author)
This study covers the latent demand outlook for antispasmodic and anticholinergic H2 blocking agents across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of “economic population”, as opposed to the demographic population within a legal...
|
|
|
Anticholinergic Therapy in Obstructive Airways Disease.
by Nicholas J. ed. GROSS (Author)
|

|
The 2009-2014 Outlook for Antispasmodic and Anticholinergic Pharmaceutical Preparations Excluding Synthetic and H2 Blocking Agents in Japan
by Icon Group International (Author)
This econometric study covers the latent demand outlook for antispasmodic and anticholinergic pharmaceutical preparations excluding synthetic and H2 blocking agents across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,000 cities in Japan. For each city in question, the percent share the city is of it's prefecture and of Japan is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-a-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for antispasmodic and...
|
|